Publication date: January 2027 Source: Current Problems in Cardiology, Volume 52, Issue 1 Author(s): Laura Pezzi, Davide Rossi, Roberta Magnano, Silvio Saraullo, Alberto D’Alleva, Mario Di Marino, Claudio Scollo, Francesca Pierfelice, Eugenio Genovesi, Giulia Renda, Sabina Gallina, Massimo Di Marco
Targeting the NO–sGC–cGMP pathway in cancer therapy-related cardiac dysfunction: the emerging role of vericiguat. // Current Problems in Cardiology. – URL: https://www.sciencedirect.com/science/article/pii/S0146280626002148?dgcid=rss_sd_all
Targeting the NO–sGC–cGMP pathway in cancer therapy-related cardiac dysfunction: the emerging role of vericiguat. Current Problems in Cardiology. https://www.sciencedirect.com/science/article/pii/S0146280626002148?dgcid=rss_sd_all
“Targeting the NO–sGC–cGMP pathway in cancer therapy-related cardiac dysfunction: the emerging role of vericiguat.” Current Problems in Cardiology.
@article{article42667,
title = {Targeting the NO–sGC–cGMP pathway in cancer therapy-related cardiac dysfunction: the emerging role of vericiguat},
journal = {Current Problems in Cardiology},
url = {https://www.sciencedirect.com/science/article/pii/S0146280626002148?dgcid=rss_sd_all}
}